baber/WOPTO huggingface dataset:
Patent MX-2021006221-A (MX)
Title: Absorbent article.
Inventor: LIU XIAOMIN
IPC: A61F13/49
Filed: 2018-12-24
Abstract: An absorbent article (10) can have a first body panel (20), a second body panel (30), and an absorbent panel (40) spanning between connecting the first body panel (20) and the second body panel (30). The absorbent panel (40) is narrower in width than each of the first body panel (20) and the second body panel (30) and is bonded to at least one of the first body panel (20) and/or second body panel (30) with at least one bond region (102,104) having a first bond strength and at least two bond regions (106,108) having a second bond strength greater than the first bond strength. Following use of the absorbent article (10) by a wearer, the portion of the absorbent panel (40) bonded to the body panel (20,30) with weaker bond strength can be separated from the body panel (20,30). The absorbent article (10) can be reconfigured from a wear configuration into a disposal configuration such that the portion of the material forming the body panel (20,30) which has been separated from the absorbent panel (40) can be inverted over the absorbent article (10).
Patent MX-2021006458-A (MX)
Title: Yeast cell wall enriched in mannan oligosaccharide protein.
Inventor: COX DONALD J
IPC: C12P19/04
Filed: 2016-10-13
Abstract: The present invention relates to yeast cell wall 5 compositions enriched with mannose, mannose extracts and processes for making the same.
Patent MX-2021007085-A (MX)
Title: Human interleukin-2 variant or derivative thereof.
Inventor: ZHANG LIANSHAN
IPC: A61P37/00
Filed: 2019-12-20
Abstract: Provided is a human interleukin-2 (IL-2) variant having one or more amino acid mutations or a derivative thereof. The IL-2 variant or derivative thereof has increased stability compared to wild-type IL-2 and improved properties as an immunotherapeutic agent. Also disclosed are an immunoconjugate and a pharmaceutical composition which comprise the human IL-2 variant or derivative thereof, a polynucleotide molecule encoding same, a vector, a host cell and a preparation method therefor, as well as the pharmaceutical uses of the IL-2 variant or derivative thereof and the immunoconjugate or pharmaceutical composition comprising the L-2 variant or derivative thereof.
Patent MX-2021009736-A (MX)
Title: Safe insulin needle.
Inventor: ZHANG HONGJIE
IPC: A61M5/32
Filed: 2020-01-21
Abstract: Disclosed is a safe insulin needle, comprising a protection sleeve (1), a needle tubing (2), a safety protection sleeve (3), a pressing seat (4), and a needle holder (5), wherein the needle tubing (2) is arranged on the central axis of the needle holder (5); the pressing seat (4) is sheathed over the upper portion of the needle holder (5); the safety protection sleeve (3) is sheathed on the needle holder (5) and the pressing seat (4) as a whole; the upper portion of the safety protection sleeve (3) is connected to and cooperates with the pressing seat (4); the needle tubing (2) protrudes out of the top end of the upper portion of the safety protection sleeve (3); the lower portion of the safety protection sleeve (3) is connected to and cooperates with the lower portion of the needle holder (5); the protection sleeve (1) is sheathed on the safety protection sleeve (3) and the needle tubing (2) as a whole; and the lower portion of the protection sleeve (1) is connected to and cooperates with the lower portion of the safety protection sleeve (3). Since the pressing seat (4) is additionally provided, and connection structures between the pressing seat (4) and the safety protection sleeve (3) and between the pressing seat (4) and the needle holder (5) are redesigned, the stability of the safety protection sleeve (3) in an axial plane is improved while achieving self-locking of the safety protection sleeve (3) in a circumferential direction and in an axial direction, such that the stability of the entire structure is ensured, and the safety factor of a product is increased. The entire product is small in terms size, and the components are fitted in a compact manner with a high fitting degree, and can be completely assembled in one step.
Patent MX-2021009829-A (MX)
Title: Salivary biomarkers of brain injury.
Inventor: BELLI ANTONIO
IPC: C12Q1/6883
Filed: 2020-02-14
Abstract: Methods of diagnosing, monitoring, treating, and predicting the course of traumatic brain injury (TBI), including mild traumatic brain injury (mTBI), include determining a level of at least one RNA biomarker (e.g., miRNA) in a saliva sample from a subject. Also described are sensor elements, detection systems, compositions, and kits for diagnosing, monitoring, treating, and predicting the course of TBI.
Patent MX-2021010845-A (MX)
Title: Unit pixel comprising light emitting diodes, unit pixel module, and display device.
Inventor: HONG SEUNG SIK
IPC: H01L33/48
Filed: 2020-03-30
Abstract: A unit pixel according to an embodiment of the present disclosure comprises: a transparent substrate; a plurality of light emitting diodes arranged on the transparent substrate; an adhesive layer for bonding the light emitting diodes to the transparent substrate; a step adjustment layer which covers the light emitting diodes and is bonded to the adhesive layer; and connection layers which are disposed on the step adjustment layer and are electrically connected to the light emitting diodes, wherein the step adjustment layer has an uneven pattern formed along the edge thereof.
Patent MX-2021013751-A (MX)
Title: Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof.
Inventor: COHEN FREDERICK
IPC: A61P35/00
Filed: 2020-05-15
Abstract: Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.
Patent MX-2021014602-A (MX)
Title: Method for controlling a fermentation process.
Inventor: NANDY SUBIR KUMAR
IPC: C12N1/30
Filed: 2020-06-11
Abstract: The present invention relates to a fermentation process for the fermentation of at least one microorganism, wherein the fermentation process comprises the steps of (a) allowing a fermentation broth comprising the at least one microorganism to flow in the fermentation reactor; (b) supplying a carbon-substrate to the fermentation reactor allowing the gaseous carbon-substrate to be dissolved, or partly dissolved, in the fermentation broth; (c) supplying a nitrogen-substrate to the fermentation reactor allowing the gaseous nitrogen-substrate to be dissolved, or partly dissolved, in the fermentation broth; and (d) maintaining a nitrate concentration of the fermentation broth below 0.035 g/l, and/or maintaining a nitrate concentration of the fermentation broth below 0.01 g nitrate/g biomass; wherein the at least one methanotrophic organism comprises at least one methanotrophic microorganism.
Patent MX-2022001872-A (MX)
Title: Absorbent paper made by a process comprising a creping step on a multilayer creping belt having connected openings.
Inventor: SCHUH BRIAN J
IPC: D21F1/00
Filed: 2020-08-31
Abstract: An absorbent sheet made by a process that includes the steps of forming a nascent web from an aqueous papermaking furnish, and creping the nascent web on a multilayer belt that includes (i) a first layer made from a polymeric material having a plurality of overlapping openings, and (ii) a second layer attached to the first layer, with the nascent web being deposited onto a surface of the first layer. The absorbent sheet includes a plurality of hollow domed regions projecting from a side of the absorbent sheet.
Patent MX-2022004207-A (MX)
Title: Fitting for connecting to a tubular element, tubing connection and a method for connecting a fitting to a tubular element.
Inventor: SALEHI-BAKHTIARI MANOUCHEHR
IPC: F16L13/14
Filed: 2017-04-26
Abstract: A fitting (3, 3') for connecting to a tubular element (5, 5') having a first end section (9, 9') comprising at least one first connection element (21, 21'), wherein the diameter of at least a part of the first connection element (21, 21') can be reduced in a radial direction in order to produce a connection, wherein the first connection element (21, 21') comprises at least one first hook element (21, 21') and/or at least one first crimp (237, 437) configured to be connected in force-fit and/or form-fit manner to at least one second crimp (7, 7') and/or at least one second hook element (235) formed on the outer surface of the tubular element, when the diameter of at least a part of the first connection element (21, 21') is reduced, as well as a tubing connection and a method for connecting a fitting to a tubular element.
Patent MX-2022006839-A (MX)
Title: Bioprinting system.
Inventor: CHALONY GREGOIRE ANDREW FRANCIS
IPC: A61B17/00
Filed: 2020-12-07
Abstract: The present disclosure provides a bioprinting system (100) for printing a liquid directly onto a subject. The bioprinting system (100) comprises a bioprinting assembly (102). Optionally, a robotic arm (104) and a control system (150) are provided. The bioprinting assembly (102) may be coupled to the robotic arm (104) to be positionable relative to the subject. The bioprinting assembly (102) is configured to dispense the liquid onto the subject and comprises a reservoir (120) for holding the liquid and a loading mechanism (134) to prime the reservoir (120) with the liquid directly prior to printing. The loading mechanism (134) has a one way inlet to permit liquid to be loaded into the reservoir (120) and prevent fluid from exiting the reservoir via the one way inlet. There is also provided associated methods.
Patent MX-2022009684-A (MX)
Title: Process and plant for gas mixtures containing acid gas treatment.
Inventor: DE ANGELIS ALBERTO RENATO
IPC: B01D53/14
Filed: 2021-02-05
Abstract: A process for treatment of gas mixtures containing acid gas, for the removal of said acid gas from the gas mixtures, comprising an absorption step performed on a gas mixture containing acid gas by means of a solvent system containing at least one liquid absorption solvent for removing from the gas mixture the acid gas contained therein and forming a lean gas mixture, from which at least part of the acid gas have been removed, and an enriched solvent containing the acid gas; and a regeneration step, in which the enriched solvent is subjected to a gas/liquid separation step by a flash process to be separated from the absorbed acid gas and to produce an acid gas flow and a regenerated solvent which is recirculated to the absorption step; wherein the solvent system contains at least one liquid absorption solvent selected from switchable ionic liquids.
Patent MX-2022010463-A (MX)
Title: Structured silica clad silica optical fibers.
Inventor: NEUBERGER WOLFGANG
IPC: C03B37/012
Filed: 2021-02-25
Abstract: A new type of all-silica optical fiber is described; a Structured Silica Clad Silica (SSCS) optical fiber, whose cladding is structured to provide mode mixing within the core; and/or to have an average effective refractive index. Its cross-section is essentially symmetrical, it can be used, among other objects, to provide flatter, more speckle-free outputs from fiber lasers, or other limited mode photonic sources. Building the new fiber structure around a rare earth doped laser core provides a better fiber laser/amplifier for cladding pumping. The structured silica cladding contains paired layers, in which a down doped silica layer is followed by a layer of pure, or lesser down-doped, or even up-dope silica, and die number of paired layers is, typically, from 5 to about 25, and, generally, within the paired layers the ratio of thickness of the higher RI layer of silicate the down-doped silica is very broad, lying between about 0.0625 to about 16, depending on the intended use of the SSCS fibers. In some versions, the main core material can be up-doped silica with pure silica or down-doped silica as the primary second component.
Patent MX-2022010543-A (MX)
Title: Methods for treating tobacco material, apparatus for treating tobacco material, treated tobacco material and uses thereof.
Inventor: LINK MATTHIAS
IPC: A24B3/12
Filed: 2021-02-25
Abstract: The present invention provides a method of treating tobacco material comprising combining pre-cut and/or pre-expanded stem with lamina to form an initial combination of stem and lamina; cutting the initial combination of stem and lamina; expanding the combination of stem and lamina; and intermittently contacting the expanded combination of stem and lamina with a heated surface to produce a treated tobacco material. Also provided is an apparatus for treating tobacco material. The invention also provides treated tobacco material, as well as products comprising the same.
Patent MX-2022014428-A (MX)
Title: Ketone functionalized polymers, methods of making ketone functionalized polymers, and compositions including the same.
Inventor: SWENSON MATTHEW
IPC: C08F220/14
Filed: 2021-05-20
Abstract: A ketone-containing polymer can provide for a paint having increased scrub resistance and decreased changes in viscosity, while maintaining quick dry times. In particular, the polymers may be used in compositions for traffic markings and industrial coatings.
Patent MX-2022015551-A (MX)
Title: Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-meth ylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl ]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine.
Inventor: STIRN SCOTT
IPC: A61K9/00
Filed: 2021-06-09
Abstract: The present disclosure relates to the fields of chemistry and medicine, more particularly to processes for making 4-(2-chloro-4-methoxy-5-methylphenyl)-<i>N</i>-[(1<i>S</i>)-2 -cyclopropyl-1-(3 -fluoro-4-methylphenyl)ethyl]-5-methyl-<i>N</i>-prop-2-ynyl-1,3 -thiazol-2-amine (Compound 1), pharmaceutically acceptable salts, and crystalline forms thereof, for the treatment of congenital adrenal hyperplasia (CAH).
Patent MX-PA00008360-A (MX)
Title: Method for producing monodispersed anion exchangers with strong basic functional groups.
Inventor: RUDIGER SEIDEL
IPC: A23L27/30
Filed: 2000-08-25
Abstract: Preparation of monodisperse anion exchanger with strongly basic functional groups in the resin core or shell comprises polymerizing a monovinyl aromatic compound(s) and a polyvinyl aromatic compound(s), aminomethylating with phthalimide derivatives, alkylating to give a weak anion exchanger with tertiary amino groups and partially loading with strong acids. Preparation of monodisperse anion exchanger with strongly basic functional groups in the resin core or the resin shell comprises reacting monomer droplets of a monovinyl aromatic compound(s) and a polyvinyl aromatic compound(s) to give a monodisperse, crosslinked bead polymer, aminomethylating with phthalimide derivatives and reacting to give a bead polymer, alkylating to give a weak anion exchanger with tertiary amino groups and partially loading with strong acids. An Independent claim is included for the obtained anion exchanger.
Patent MX-PA01006738-A (MX)
Title: Communications prioritizer.
Inventor: CONNER JOE
IPC: G06Q10/10
Filed: 1999-12-15
Abstract: A method of sorting a received information message in which a source of delivery of the message is indicated by a unique identifier accompanying the message, for example, in an e-mail or voice message system. The method includes steps of receiving the message, looking-up the identifier in a database, assigning a code for the message per the result of the step of looking-up, and prioritizing or forwarding the message according to the code.
Patent MX-PA01009744-A (MX)
Title: Method for producing unsaturated carboxylic acids and unsaturated nitriles.
Inventor: LEONARD EDWARD BOGAN JR
IPC: B01J27/057
Filed: 2001-09-27
Abstract: Unsaturated carboxylic acids are produced by the vapor phase catalytic oxidation of mixtures of alkenes and alkanes in the presence of a catalyst containing a mixed metal oxide. Similarly, unsaturated nitriles are produced by the vapor phase catalytic oxidation of alkenes or mixtures of alkenes and alkanes and ammonia in the presence of a catalyst containing a mixed metal oxide.
Patent MX-PA02004517-A (MX)
Title: Centralised cryptographic system and method with high cryptographic rate.
Inventor: DAVID GUHL
IPC: H04N21/418
Filed: 2000-11-02
Abstract: In a system of distributed services such as pay television, the data exchanged between a management centre and user modules use cryptographic means to guarantee authenticity and confidentiality of data. The requirements for cryptographic processing in the management centre are important; hence the invention concerns a cryptographic system combining modularity and security, for the cryptographic operations, of monolithic security units such as smart cards.
Patent MX-PA02006195-A (MX)
Title: Method and device for the maskfree production of biopolymers by means of a light diode array.
Inventor: EIPEL HEINZ
IPC: B01J19/00
Filed: 2000-12-27
Abstract: The invention relates to a method and a device for the lightcontrolled synthesis of biopolymers on surfaces. Patterns of individual sequences (20) are produced on the surfaces by representing an arrangement (1) of electrically and individually controllable light diodes (2).
Patent MX-PA02006254-A (MX)
Title: Perfume compositions with enhanced viscosity and process for their preparation.
Inventor: BERTLEFF WERNER
IPC: D06M13/00
Filed: 2000-12-20
Abstract: A perfume composition which is obtainable by adding to 100 parts by weight of a mixture of (A) 10 to 95 % by weight of at least one perfume compound and (b) 5 to 90 % by weight of at least one polyamine, the sum of (a) and (b) being always 100 %, 0.1 to 20 parts by weight of at least one crosslinking agent having at least two groups which react with primary or secondary amino groups of the polyamine and crosslinking the mixture, andor adding 0.1 to 30 parts by weight of a thickening agent.
Patent MX-PA02009524-A (MX)
Title: Compositions containing polycarbonate.
Inventor: ANDERS SIEGFRIED
IPC: C08K5/101
Filed: 2001-03-19
Abstract: The invention relates to compositions containing polycarbonate and ester from a linear carboxylic acid and from a branched alcohol, and to products produced from these compositions.
Patent MX-PA02009875-A (MX)
Title: Sanitary napkin.
Inventor: DREVIK SOLGUN
IPC: A61F13/56
Filed: 2001-04-03
Abstract: The present invention relates to an absorbent article (1) in the form of a sanitary napkin, a panty liner or an incontinence protector for women. According to the invention, the article (1) includes outwardly projecting, flexible flaps (6, 7) which extend beyond respective sides of the abosrbent body (2) along a tapering part of said body and have outer longitudinal edges (13, 14) which in the unfolded state of the flaps are inclined relative to the longitudinal symmetry axis (A A) of the article at an angle such that the distance between the outer sides of the flaps and the longitudinal symmetry axis of the article decreases in a direction towards the rear end of the article, and in that the outer longitudinal edges (13, 14) of the flaps in the unfolded state of said flaps are each inclined to the longitudinal symmetry axis (A A) of the article at a first angle (agr;) which is larger than the angle (bgr;) at which a first imaginary line (B B, B B ) is inclined to said longitudinal symmetry axis, said first imaginary line passing through the outer limitation point of the abosrbent body in its widest part and the outer transversal limitation point of the rear end of the absorbent body on the same side of the longitudinal symmetry axis (A A) as the edge in question, although being smaller than three times this angle of inclination.
Patent MX-PA03003586-A (MX)
Title: Treatment of premature ejaculation.
Inventor: BOOLELL MITRADEV
IPC: C07D487/04
Filed: 2001-11-19
Abstract: This invention relates to the use of cyclic guanosine 3',5'-monophosphate phosphodiesterase type five inhibitors, including in particular the compound sildenafil, for the treatment of premature ejaculation in patients with normal erectile function.
Patent MX-PA03003788-A (MX)
Title: Method for customizing seismic explosives.
Inventor: FLEURE THOMAS J
IPC: G01V1/13
Filed: 2001-10-26
Abstract: A method for identifying optimal seismic energy source configurations for a selected seismic survey area. Physical properties of the surface or near-surface soil or rock are assessed and are tested to determine the response of such soil to energy source characteristics and geometries. A test model for a source is generated and is projected to create a far-field seismic response model. A seismic event is initiated within the survey area to measure seismic data, and such measured data is compared against the far-field seismic response model. Differences can be assessed to permit modifications to the model, and the model can be tested for different types and configurations of seismic source energy sources.
Patent MX-PA03004144-A (MX)
Title: DECONTAMINATION OF ANIMAL FEED CONTAINING PRION (eg. BSE agent).
Inventor: KEMP PHILIP WILLIAM
IPC: A23K1/10
Filed: 2001-11-14
Abstract: A method of producing an animal feed that is free from transmittable degenerativeencephalopathies is provided. Central to the method is alkali treatment of animalmaterial at a pH of at least 8.5 under temperature conditions below 100 C at atmospheric pressure. This method provides a decontaminated animal feed produced under relatively low temperature and pressure conditions that are achievable instandard animal carcass rendering facilities.
Patent MX-PA03004830-A (MX)
Title: Custom molded tennis elbow pad assembly.
Inventor: DARCEY THOMAS D
IPC: A61F5/02
Filed: 2001-11-30
Abstract: A tennis elbow pad assembly product for relieving the symptoms of lateral epicondylitis is disclosed. The tennis elbow pad assembly product includes an outer pouch formed of a moisture-impervious material. A pad is positioned in the pouch in substantially moisture-free conditions and sealed therein against entry of moisture until use. The pad is adapted for being positioned against and molded onto a forearm in the region of the elbow for lying in closely-conforming relation against and applying radially-directed pressure to the common tendon attachment and grasping and supination muscles associated with the radial-humeral joint and the lateral epicondyle of a forearm and hardened into a rigid structure for therapeutic use. The pad includes an initially flexible substrate impregnated or coated with a reactive system. The system remains stable when maintained in substantially moisture-free conditions and hardens upon exposure to moisture to form a rigid, self-supporting structure having a shape that conforms to the forearm to which the pad is molded during curing. The pad also includes a flexible outer layer enclosing the substrate and a support cooperating with the pad for maintaining the pad in its closely-conforming position against the forearm.
Patent MX-PA03007144-A (MX)
Title: Human monoclonal antibodies to fc alpha receptor (cd89).
Inventor: JAN VAN DE WINKEL
IPC: A61K47/48
Filed: 2002-02-11
Abstract: Human monoclonal antibodies which bind specifically to Fc alpha receptor (CD89), including monoclonal antibodies which react specifically to Fc receptor for IgA of human effector cells are disclosed. The binding agents, e.g., antibodies are useful for targeting human effector cells (e.g. macrophages) against a target cell (e.g. a cancer cell, an infectious agent, etc.). for this purpose, bifunctional antibodies or heteroantibodies can be constructed containing the binding region derived from an anti-Fc-alpha receptor antibody and the binding region of a target-specific antibody. Targeted effector cells can specifically lyse target cells.